For example, in breast cancer, studies have found that the activation of the JUN TF binding to specific enhancers in CAFs drives the reprogramming of these enhancers, thus activating the expression of a series of genes that promote tumor invasiveness and metastasis [247]. Here, JUN is linked to breast carcinoma.